"Breakthrough Vaccine Accelerates Growth with 'Very Promising' Results"
A vaccine developed to prevent bacteria-caused diarrhea has shown promising results in combating Campylobacter infections and promoting faster growth in infant nonhuman primates. The HydroVax technology, which is also being used for other diseases, has the potential to reduce diarrhea-associated deaths and address infant growth stunting. The vaccine, based on a hydrogen peroxide-based technology called HydroVax, was evaluated in pregnant monkeys and their babies. The vaccinated baby monkeys showed improved growth rates compared to the unvaccinated ones. The vaccine also provided protection against severe diarrhea and reduced diarrhea-associated deaths. Further research is needed to improve the vaccine's effectiveness and explore the use of nutritional supplements alongside vaccination.
